Vimarsana
Biggest News Aggregation in the World

Page 4 - Precision Surgery News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Surgery Today - Breaking & Trending Today

Pearl Precision Surgery: Changes In Women's Healthcare Quality and Affordability Amongst US Employers - Vimarsana News

Pearl Precision Surgery: Changes In Women's Healthcare Quality and Affordability Amongst US Employers

/PRNewswire/ -- With healthcare costs continuing to rise, it's no surprise that employers are eager to find new solutions to better serve their employees and...

Pearl Precision Surgery: Changes In Women's Healthcare Quality and Affordability Amongst US Employers - Vimarsana News

Pearl Precision Surgery: Changes In Women's Healthcare Quality and Affordability Amongst US Employers

PORTLAND, Ore., Feb. 1, 2022 /PRNewswire/ -- With healthcare costs continuing to rise, it's no surprise that employers are eager to find new solut...

Pearl Precision Surgery: Changes In Women's Healthcare Quality and Affordability Amongst US Employers - Vimarsana News

Pearl Precision Surgery: Changes In Women's Healthcare Quality and Affordability Amongst US Employers

/PRNewswire/ -- With healthcare costs continuing to rise, it's no surprise that employers are eager to find new solutions to better serve their employees and...

Imaging drug that illuminates ovarian cancer tissue when exposed to fluorescent light gets FDA approval - Vimarsana News

Imaging drug that illuminates ovarian cancer tissue when exposed to fluorescent light gets FDA approval

The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.

FDA approves 'glowing tumor' drug to help surgeons identify ovarian cancer cells - Vimarsana News

FDA approves 'glowing tumor' drug to help surgeons identify ovarian cancer cells

Cytalux (pafolacianince), a drug that binds to ovarian cancer tissue and glows when exposed to fluorescent light, has been approved by the U.S. Food and Drug Administration (FDA) to help surgeons detect ovarian tumors during surgical procedures in patients.